Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol-HFA for Exercise-Induced Bronchoconstriction
NCT00634829Phase 3Terminated
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salbutamol in Exercise-induced bronchoconstriction (EIB) (3 arms). Primary endpoint: Maximum percentage fall in FEV1 from Pre-Exercise FEV1. Started Feb 2008; status: terminated.
02
Drugs
salbutamol
03
Conditions
Exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00634829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634829.